| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |